BioAscent was recognised as the UK’s fastest-growing drug discovery CRO, ranking first in the outsourcing category and third in the overall listing published in the 2020 Alantra Pharma Fast 50 report.
The annual report is made up of those businesses that have increased their revenues at the fastest rate over the previous two years. BioAscent had recorded a compound annualised growth rate of 67% during that period.
